title: T cell antigen receptor engagement stimulates c-raf phosphorylation and induces c-raf-associated kinase activity via a protein kinase C-dependent pathway.
abstract: The c-raf kinase has been shown to be activated following stimulation of several tyrosine kinase growth factor receptors. We examined changes in c-raf following engagement of the T cell receptor for antigen (TCR), a stimulus which activates both a non-receptor tyrosine kinase and protein kinase C (PKC). We found that activation of the T-cell receptor on the T cell hybridoma 2B4 causes a rapid and stoichiometric hyperphosphorylation of c-raf and an increase in c-raf-associated kinase activity. Phosphoamino acid analysis showed that the phosphorylation was entirely on serine residues. High-resolution phosphopeptide mapping showed the appearance of a single major new phosphopeptide with TCR stimulation. That phosphopeptide was shown to comigrate with the major new phosphopeptide induced in response to phorbol ester. When cells were depleted of PKC by pretreatment with high concentrations of phorbol ester, TCR stimulation was no longer capable of inducing c-raf-associated kinase activity. To determine whether activation of the tyrosine kinase alone would activate c-raf, we examined the 2B4 variant cell line FL.8. In response to Thy-1 stimulation, these cells activate the tyrosine kinase but not protein kinase C due to a deficiency in TCR eta chain expression. We found that in contrast to Thy-1 stimulation of 2B4 cells, stimulation of FL.8 cells does not lead to the induction of c-raf-associated kinase activity, although phorbol ester activates the kinase to an equivalent degree in both cells. We conclude that T cell receptor activation of c-raf occurs via phosphorylation by the serine/threonine kinase PKC. Activation of c-raf through PKC represents a mechanism distinct from that reported for tyrosine kinase growth factor receptors.
authors.affiliation: Laboratory of Viral Carcinogenesis, National Cancer Institute-Frederick Cancer Research Facility, Frederick, Maryland 21701.
authors.forename: J N
authors.initials: JN
authors.lastname: Siegel
authors.forename: R D
authors.initials: RD
authors.lastname: Klausner
authors.forename: U R
authors.initials: UR
authors.lastname: Rapp
authors.forename: L E
authors.initials: LE
authors.lastname: Samelson
mesh_terms: D000818:Animals; D002460:Cell Line; D004789:Enzyme Activation; D006825:Hybridomas; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D051379:Mice; D010449:Peptide Mapping; D010716:Phosphatidylinositols / Q000378:metabolism; D010766:Phosphorylation; D010768:Phosphoserine / Q000378:metabolism*; D006656:Protamine Kinase / Q000378:metabolism; D011493:Protein Kinase C / Q000502:physiology*; D011505:Protein-Tyrosine Kinases / Q000378:metabolism*; D011518:Proto-Oncogene Proteins / Q000378:metabolism*; D019908:Proto-Oncogene Proteins c-raf; D011519:Proto-Oncogenes; D011948:Receptors, Antigen, T-Cell / Q000502:physiology*; D015398:Signal Transduction
chemical_list: D010716:Phosphatidylinositols; D011518:Proto-Oncogene Proteins; D011948:Receptors, Antigen, T-Cell; D010768:Phosphoserine; D011505:Protein-Tyrosine Kinases; D006656:Protamine Kinase; D019908:Proto-Oncogene Proteins c-raf; D011493:Protein Kinase C